Precision Biosciences, Inc. · NASDAQ:DTIL
Novartis Pharma AG reported a 5.40% stake in Precision Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Novartis Pharma AG reported a 5.40% stake in Precision Biosciences, Inc., 413,581 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 413,581
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novartis Pharma AG | 5.40% | 413,581 |
| Novartis AG | 5.40% | 413,581 |
Source
Related
- Precision Biosciences, Inc.
- Novartis Pharma AG
- Precision Biosciences, Inc. shareholders
- Schedule 13G/A · Novartis Pharma AG · Aug 6, 2025
- Form 4 · Frankel Stanley · Sep 30, 2026
- Form 4 · Brown Melinda · Sep 29, 2026
- Form 4 · Germano Geno J · Sep 29, 2026
- Schedule 13G/A · Weinstein Benjamin · Aug 24, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jul 29, 2026